Novel L-Dopa and Dopamine Prodrugs Containing a 2-Phenyl-imidazopyridine Moiety

Author： Denora Nunzio Laquintana Valentino Lopedota Angela Serra Mariangela Dazzi Laura Biggio Giovanni Pal Dhananjay Mitra Ashim Latrofa Andrea Trapani Giuseppe Liso Gaetano

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.24, Iss.7, 2007-07, pp. : 1309-1324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-DOPA and dopamine in rats

By Napolitano A. Zurcher G. Da Prada M.

European Journal of Pharmacology, Vol. 273, Iss. 3, 1995-02 ,pp. : 215-221

Elsevier

Access to resources Recommend Favorite

Atipamezole, an 2 -adrenoceptor antagonist, augments the effects of l-DOPA on evoked dopamine release in rat striatum

By Yavich L. Sirvio J. Haapalinna A. Ylinen A. Mannisto P.T.

European Journal of Pharmacology, Vol. 462, Iss. 1, 2003-02 ,pp. : 83-89

Elsevier

Access to resources Recommend Favorite

L-Dopa Prodrugs: An Overview of Trends for Improving Parkinson's Disease Treatment

Current Pharmaceutical Design, Vol. 17, Iss. 32, 2011-11 ,pp. : 3482-3493

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of acute and repeated treatment with a novel dopamine D 2 receptor ligand on l-DOPA-induced dyskinesias in MPTP monkeys

By Tahar A.H. Ekesbo A. Gregoire L. Bangassoro E. Svensson K.A. Tedroff J. Bedard P.J.

European Journal of Pharmacology, Vol. 412, Iss. 3, 2001-02 ,pp. : 247-254

Elsevier

Access to resources Recommend Favorite

Half a Century of l-DOPA

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 10, 2009-07 ,pp. : 880-893

Bentham Science Publishers

Access to resources Recommend Favorite